Corrigendum to 'Concomitant delivery of paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy' NANO 14 (2018) 1301-1313.

Gupta, Dikshi; Kumar, Manoj; Tyagi, Priyanka; Kapoor, Sumeet; Tyagi, Amit; Barman, Tarani Kanta; Kharbanda, Surender; Kufe, Donald; Singh, Harpal.

Afiliação

Gupta D; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India. Electronic address: gupta.dikshi@gmail.com.
Kumar M; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India.
Tyagi P; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India.
Kapoor S; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India.
Tyagi A; Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, Delhi, 110 054, India.
Barman TK; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India.
Kharbanda S; Department of Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School, Boston, MA 02215, USA.
Kufe D; Department of Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School, Boston, MA 02215, USA.
Singh H; Centre for Biomedical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, 110 016, India. Electronic address: harpal@cbme.iitd.ac.in.

Nanomedicine ; 14(7): 2129, 2018 10.

Article em En | MEDLINE | ID: mdl-30048637

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article